Skip to main content

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Employer Contracts to Provide Full Suite of Digital Health Solutions

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has inked two new contracts for the company’s full suite of chronic condition management solutions. DRIO solutions were chosen by the two employers to “help improve overall employee health.” Both contracts — one with a global Fortune 1000 company and one with a global sports organization — are set to begin in 2023. DarioHealth noted that the contracts are an indication of the company’s continued growth in the employer space. Specifically, the companies are looking to “improve the health of employees living with diabetes, high blood pressure, weight management needs, musculoskeletal and behavioral health needs using the company’s single digital therapeutics platform.” DarioHealth has been involved in a monthslong pilot program with one of the employers, and the success of that program led to the new contract. “We continue to see strong demand for our integrated suite of solutions as employers realize the benefits of a single approach to managing related chronic conditions,” said DarioHealth president Rick Anderson in the press release. “We look forward to launching these new accounts and demonstrating the power of Dario’s single, seamless experience to improve health and outcomes.”

To view the full press release, visit https://ibn.fm/PF4C8

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. The company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. DRIO’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.